$IPAR

Goldman downgrades Interparfums as re-rated valuation limits upside

Goldman Sachs downgraded Interparfums Inc. (IPAR) to neutral from buy and raised its 12-month price target to $129 from $110, citing a forward P/E re-rating from 16x to 22x and limited further multiple upside. Goldman forecasts FY2026 revenue $1.51B and FY2027 $1.669B, with EPS estimates slightly below consensus, and expects organic growth to accelerate.

Original reporting
Published Aug 10, 2026, 8:44 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$IPAR
Neutral
medium confidence
Mentioned
$IPAR
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$IPARNeutralMed
01

Why it matters

Traders may reprice the stock around the analyst’s view that valuation upside is limited, even as forecast revisions point to modest fundamental improvement.

02

Market read

A sell-side downgrade with a higher PT but low implied upside can shift positioning and options pricing, especially if the market was expecting more multiple expansion.

03

What to watch

The article notes a $250 million authorized buyback likely directed toward European shares, which could support the European listing even if the U.S. rating is cut.

Relevance 7/10Novelty 6/10Timing: pre-market today (analyst downgrade and PT update reported at 08:44 UTC)

Background

Goldman initiated coverage earlier and is now re-rating Interparfums’ forward P/E multiple from 16x to 22x, citing execution and a growth inflection.

Company-level read

Ticker impact

$IPARNeutralMedium confidence
Context

Goldman downgraded Interparfums Inc. to neutral from buy and set a $129 12-month target, citing limited further multiple expansion.

Expected impact

Near-term downside risk from the rating cut, with upside capped unless execution or sector re-rating accelerates beyond the bank’s assumptions.

Evidence & confidence

The article’s actionable change is the analyst rating downgrade plus a higher PT, but the PT still implies only about 5% upside and explicitly limits additional multiple expansion.

Market effects

A broader consumer staples or fragrance sector re-rating is cited, but the bank frames valuation headroom as constrained.

Goldman highlights a valuation discount in the European-listed subsidiary, implying relative-value interest between listings.

Limited, mostly confined to consumer staples/fragrance valuation expectations rather than macro or cross-asset drivers.

Counterpoint

The higher PT and raised U.S. revenue estimates suggest fundamentals are improving, so the downgrade may be more about valuation than business deterioration.

Key entities

  • Interparfums Inc.

    Fragrance maker whose rating and valuation assumptions were updated by Goldman.

  • Interparfums SA

    European-listed subsidiary kept at a buy rating with a noted valuation discount versus the U.S. listing.

  • Goldman Sachs

    Issued the downgrade to neutral and updated the 12-month price target and forecast assumptions.

Related articles

$IPARMed

Inter Parfums (NASDAQ:IPAR) Posts Better

Inter Parfums (NASDAQ:IPAR) reported Q2 CY2026 revenue of $341 million, up 2.1% year on year and 0.6% above market expectations, according to the company. Full-year revenue guidance was $1.48 billion at the midpoint, 1.5% below analysts’ estimates. GAAP EPS was $0.95, 2.1% below consensus. The stock was flat at $128.43 after results.

$IPARMed

INTERPARFUMS INC (IPAR): Results of Operations and Financial Condition

INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 7 ex991_1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. REPORTS 2026 SECOND QUARTER NET SALES 2026 Second Quarter Conference Call Scheduled for August 5, 2026 New York, New York, July 22, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums”

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.